LINK ALTERNATIF MBL77 Options
Not all patients with CLL call for therapy. Inspite of all current improvements, the iwCLL continue to recommends watchful observation for patients with asymptomatic sickness.86 This advice relies on not less than two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).gene